Crestline Management, LP Axonics, Inc. Transaction History

Crestline Management, LP

  • $1.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$43.74 - $62.76 $2.87 Million - $4.12 Million
-65,669 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$50.01 - $73.35 $935,587 - $1.37 Million
18,708 Added 39.84%
65,669 $3.68 Million
Q3 2021

Nov 12, 2021
BUY
$59.21 - $78.66 $2.78 Million - $3.69 Million
46,961 New
46,961 $3.06 Million

Others Institutions Holding AXNX

# of Institutions
234
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email